Global Cell Therapy Market Charged to grow at the CAGR of 23.27 % from 2018 to 2022 Presents “Global Cell Therapy Market 2017-2021” New Document to its Studies Database

About Cell Therapy

Cell therapy products, which are derived from stem cells, tissues, and organs grown in laboratories, are injected into patients. The growing number of clinical trials, government and private funding, and increasing number of partnerships between companies are driving the growth of the global cell therapy market. Cell therapy products that are available in the market are based on autologous and allogenic cells. The demand of cell therapy treatment is increasing. This is because cell therapy products can be used for personalized treatment.

Technavio’s analysts forecast the global cell therapy market to grow at a CAGR of 23.27% during the period 2017-2021.

Covered in this report 
The report covers the present scenario and the growth prospects of the global cell therapy market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.

The market is divided into the following segments based on geography: 
• Americas 

Technavio's report, Global Cell Therapy Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

 Request For Sample Report @                                     


Key vendors 
• Dendreon 
• Mesoblast 
• Vericel

Other prominent vendors 
• AlloCure 
• Amorcyte 
• Anterogen 
• Antibe Therapeutics 
• Astellas Pharma 
• Athersys 

Market driver 
• Increase in prevalence of chronic diseases 
• For a full, detailed list, view our report

Market challenge 
• High cost of clinical trials and cell therapy doses 
• For a full, detailed list, view our report

Market trend 
• Proliferation of strategic alliances and royalty payments 
• For a full, detailed list, view our report

Key questions answered in this report 
• What will the market size be in 2021 and what will the growth rate be? 
• What are the key market trends? 
• What is driving this market? 
• What are the challenges to market growth? 
• Who are the key vendors in this market space?

You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.


Complete Report Details @   


Table Of Contents:      

PART 01: Executive summary 
PART 02: Scope of the report 
PART 03: Research Methodology 
PART 04: Introduction 
• Overview 
• Government funding and support 
PART 05: Market landscape 
• Overview 
• Market size and forecast 
• PART 06: Pipeline portfolio 
• Overview 
• Regulatory framework for cell therapy products 
• Pipeline analysis 
• Five forces analysis 
PART 07: Segmentation by application 
• Overview 
• Dermatology 
• Musculoskeletal 
• Ocular 
• Cardiovascular 
PART 08: Segmentation by end-user 
• Hospitals and clinics 
• ASCs 
• Regenerative medicine centers 
PART 09: Segmentation by geography 
• Overview 
• Americas 
PART 10: Decision framework 
PART 11: Drivers and challenges 
• Market drivers 
• Market challenges 
PART 12: Market trends 
• Focus on business strategies 
• Proliferation of strategic alliances and royalty payments 
• Geographic expansion of gene therapy 
PART 13: Vendor landscape 
• Competitive landscape 
• PART 14: Key vendor analysis 
• Dendreon 
• Mesoblast 
• Vericel 


Contact Info:
Name: Norah Trent
Email: Send Email
Organization: Wiseguyreports
Address: Office No. 528/524, Amanora Chambers, Magarpatta Road, Hadapsar Pune, Maharashtra 411028
Phone: +1 (339) 368 6938 (US) +44 208 133 9349 (UK)

Release ID: 412444